CORONA Covid Shots Linked to Surge in Rare Autoimmune Disease, Study Finds

Cardinal

Chickministrator
_______________

A new study has linked Covid mRNA shots to a rare autoimmune disease that started to surge in 2021.

Scientists analyzed soaring cases that emerged in Yorkshire, England.

According to the peer-reviewed study, published in the renowned Lancet journal, a rare autoimmune disease surged in Yorkshire after the rollout of the Covid injections.

The number of cases peaked in 2021 and continued to surge through 2022.

Anti-MDA5 dermatomyositis is an inflammatory condition characterized by muscle weakness, skin rashes, and rapidly progressive lung disease.


The autoimmune disease is very rare.

In 2019, two people in Yorkshire, with a population of 3.6 million, tested positive for the disease.

In 2020, the number of positive cases increased to nine.

The highest number of new cases, 35, was reported in 2021, followed by a decrease to 16 new cases in 2022.

The recent increase in autoimmune cases may be linked to interactions between the COVID-19 virus and vaccine RNA, according to Dr. Dennis McGonagle.

McGonagle is a clinical professor of medicine at the University of Leeds.

He is also the senior author of the study.

In addition to the Lancet study, several case studies have documented new cases of anti-MDA5 following COVID-19 vaccination.



Anti-MDA5 dermatomyositis is an autoimmune condition in which the body’s immune system attacks itself.

It can often appear without a clear cause.

Dermatomyositis typically affects the skin, muscles, and lungs.

Anti-MDA5 dermatomyositis is associated with rapidly progressive lung disease, which gives the condition a poor prognosis.

MDA5 is a protein found outside of muscles and tissues, with a high concentration in the lungs.

When the body produces anti-MDA5 antibodies to target MDA5, it can lead to the deterioration of related organs and tissues.

MDA5 can recognize and attach to foreign RNA, such as COVID-19 RNA.

Upon detection, it triggers other immune cells to combat the foreign invader or respond to vaccination.


Dr. McGonagle explains:

“We think that … [this happens] because MDA5 is the receptor or docking site for viral RNA, and that this in some way triggers the antibody against it.”

In a COVID-19 infection, binding of MDA5 to RNA can lead to excessive MDA5 activity, according to Dr. Pradipta Ghosh, another corresponding author of the study.

Ghosh is the director of the Institute for Network Medicine at the University of California–San Diego.

READ MORE – CDC Admits Covid Shots Killed 500,000 Children & Young Adults
 
Top